Matching slides 41,369
Current window 31,801-31,830
Pages 1,379
Rows per page 30
Component: Calloutclear collectionreset all

Component

31,801-31,830 of 41,369

filter-aware
09
The slide highlights the financial scale and margins of the two entities involved in the acquisition.Bridge Investment Group | SPAC Presentation Deck | 16 slides · Bridge Investment Group
Pitch deck Investment bank Beat · Financials1 hit
08
The chart compares annual growth rates (FY20-FY22) and guidance against quarterly growth (Q2'22 vs Q2'23).Broadridge Financial Solutions | Results Presentation Deck | 31 slides · Broadridge
Conference presentation Investor relations Beat · What IsLoop · Cost Of Inaction1 hit
12
The slide uses a split-screen visual metaphor to contrast the two brand pillars.Canada Goose | Investor Day Presentation Deck | 161 slides · Canada Goose
Conference presentation Investor relations Beat · Need1 hit
78
The chart uses a dual-color bar approach to show current vs. potential penetration.Canada Goose | Investor Day Presentation Deck | 161 slides · Canada Goose
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
111
The slide uses a hub-and-spoke visual metaphor to show product line extension.Canada Goose | Investor Day Presentation Deck | 161 slides · Canada Goose
Conference presentation Investor relations Beat · Action1 hit
15
The slide uses a structured list format to highlight credit quality metrics.Central Pacific Financial | Investor Presentation Deck | 23 slides · Central Pacific Financial
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
13
The slide uses a football field chart visualization to compare valuation ranges.Citi | Investment Banking Pitch Book | 21 slides · Citi
Consulting deck Investment bank Beat · Evidence & Proof1 hit
11
Shows CD thermal melt data for Nivolumab, Trastuzumab, Pembrolizumab, and Ustekinumab.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations Beat · Key Takeaways1 hit
13
Data presented as bar charts showing particle counts per ml across different size ranges.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations 1 hit
18
The slide demonstrates a progression from initial screening (DLS) to final stability assessment (monomer loss) to justify the selection of specific excipient combinations.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations 1 hit
19
Includes a scatter plot, bar chart, line chart, and summary table comparing different stabilizer mixtures.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations 1 hit
20
Includes a bar chart of DOE samples, a linear regression plot of pH vs monomer, and a heatmap of sugar vs pH.Comera | Investor Presentation Deck | 22 slides · Comera Life Sciences
Conference presentation Investor relations 1 hit
07
The slide illustrates the mechanism of action of a bispecific antibody targeting DLL4 and VEGF-A.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
MTD = Maximum Tolerated Dose; PR = Partial Response; RECIST = Response Evaluation Criteria in Solid Tumors; ORR = Objective Response Rate.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The chart highlights a subset of patients with significant tumor reduction (boxed area).Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
This is a standard oncology 'swimmer's plot' or 'waterfall plot' used to demonstrate clinical efficacy.Compass Therapeutics | Investor Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
22
The slide uses a logo-grid layout to demonstrate the breadth of university partnerships across various degree categories.Coursera | Results Presentation Deck | 39 slides · Coursera
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
09
Includes a timeline at the bottom and two bar charts showing RWA and leverage exposure reduction.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
The slide uses a horizontal arrow-based timeline to represent strategic phases.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Satisfaction1 hit
40
Includes a donut chart representing currency mix for capital metrics.Credit Suisse | Results Presentation Deck | 44 slides · Credit Suisse
Deck Investor relations Beat · Action1 hit
07
The chart highlights a 54% five-year annualized TSR for Crocs, Inc.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Solution1 hit
19
The slide uses bar charts with trend arrows to visualize growth momentum.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
35
The chart highlights a 54% five-year annualized TSR for Crocs, significantly outperforming the benchmarks.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Financials1 hit
04
The slide uses a contrast between the low research/pipeline investment (left) and the high market impact/purchasing power (right) to argue for efficiency.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
05
The slide uses a comparative framework to show market potential by citing historical peak revenues of successful drugs.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Beat · Market Size1 hit
07
The slide uses a numbered list for the thesis points and a separate callout box for milestones.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-chart style visualization to show the progress of multiple drug candidates across clinical phases.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
09
Includes specific financial terms of the collaboration and regulatory milestones.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
16
Slide 16 of a pitch deck.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
17
The slide uses a structured comparison format to frame the medical problem and the proposed solution.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit